Pregnancy Outcomes

New Research from the CWMH: Quetiapine (Seroquel) and Pregnancy Data from the National Registry

The newer “atypical” or second-generation antipsychotic agents are now used  to treat a spectrum of psychiatric disorders, including schizophrenia, bipolar disorder, major depression, PTSD and other anxiety disorders.  The National Pregnancy Registry for Atypical Antipsychotics [...]

Valproic Acid: Highlighting Risk and Modifying Prescribing Patterns in Reproductive Age Women

For clinicians who have not yet discovered the incredibly thoughtful and clinically practical monthly articles from Chittaranjan Andrade in the Journal of Clinical Psychiatry, it’s time to take a look.  (Not only are these articles [...]

Predictors for New-Onset Severe Postpartum Psychiatric Disorders

A history of maternal psychiatric illness has been linked to postpartum depression (PPD), but this does not account for all instances of postpartum psychiatric illness. A recent study examined the impact of medical complications during [...]

Father’s Involvement and Early Infant Neurodevelopment: The Mediating Role of Maternal Parenting Stress

It is fairly well-known that interactions between parents and children are associated with improved developmental outcomes in children.  Previous research has primarily focused on how maternal rather than paternal involvement influences infant neurodevelopment.  A recent [...]

Antenatal Exposure to Antidepressant and Risk of Psychiatric Illness in the Child

  When we provide consultations regarding the use of antidepressants during pregnancy, one of the most difficult questions we have to answer is related to the long-term effects of prenatal antidepressant exposure. Specifically, do antidepressants [...]